CIK 0001533743 · <br>Emerging growth company
Processa Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PCSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451539785
- Phone
- 443-776-3133
- Business address
- 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960
- Former names
- Heatwurx, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | Ng George K Chief Executive Officer | Purchase | +2,136 | $2.54 | $5K | 3,649 |
| 2026-03-31 | Lin Patrick Chief Business - Strategy Off | Purchase | +1,603 | $2.54 | $4K | 3,356 |
| 2026-03-31 | Guy Wendy Chief Administrative Officer | Purchase | +1,854 | $2.54 | $5K | 3,110 |
| 2026-03-31 | Bigora Sian Chief Development Officer | Purchase | +2,107 | $2.54 | $5K | 3,711 |
| 2026-03-31 | Baluch Khoso Director | Purchase | +2,269 | $2.54 | $6K | 2,325 |
| 2026-01-01 | Young David Pres. Research & Development | Option exercise | +49 | 8,752 | ||
| 2026-01-01 | Young David Pres. Research & Development | Option exercise · Restricted Stock Units | −49 | 0 | ||
| 2026-01-01 | Lin Patrick Chief Business - Strategy Off | Option exercise | +193 | 1,753 | ||
| 2026-01-01 | Lin Patrick Chief Business - Strategy Off | Option exercise · Common Stock | −193 | 0 | ||
| 2026-01-01 | Guy Wendy Chief Administrative Officer | Option exercise | +193 | 1,256 | ||
| 2026-01-01 | Guy Wendy Chief Administrative Officer | Option exercise · Restricted Stock Units | −193 | 0 | ||
| 2026-01-01 | Bigora Sian Chief Development Officer | Option exercise | +249 | 1,604 | ||
| 2026-01-01 | Bigora Sian Chief Development Officer | Option exercise · Restricted Stock Units | −249 | 0 | ||
| 2025-10-01 | Neal James R Director | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2025-10-01 | Neal James R Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2025-10-01 | Baluch Khoso Director | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2025-10-01 | Baluch Khoso Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2025-10-01 | Pannu Geraldine Director | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2025-10-01 | Pannu Geraldine Director | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2025-10-01 | Yorke Justin W Director | Grant or award · Restricted Stock Units | +100,000 | 100,000 |
Page 4 of 6 · 119 trades